Alzheimer’s Society is the only UK charity to fund research into the cause, care and prevention of all types of dementia. Our current strategy for funding research outlines our key priorities over the coming years as well as our unique way of working with scientists and people affected by dementia in partnership.

See below details of their seven point research strategy;

1. Doubling our funding for research

We will double our commitment to funding research from £5 million in 2014 to at least £10 million per year on new research by 2017.

2. Funding high-quality research into all types of dementia

Our funding will be available to support any area of research that investigates the cause, cure, care and prevention of any type of dementia. We will fund the most promising applications assessed on their scientific quality and their relevance to people affected by dementia.

3. Supporting future generations of dementia researchers

Our Dementia Research Leaders programme will increase research into all areas of dementia by attracting, developing and retaining the best scientists, clinicians and care professionals to the field of dementia research.

4. Accelerating discovery of new drug treatments

Our Drug Discovery programme aims to develop new treatments for dementia quickly and efficiently by testing drugs already being used or still in development to treat other conditions.

5. Collecting brain tissue to support the highest quality research

The Brains for Dementia Research programme collects high-quality and well-characterised post-mortem brain tissue to provide researchers with a vital resource to help them understand the causes of dementia and find a cure.

6. Maximising the impact of research

To maximise the impact of our research, we will make sure findings are taken forward and developed into something practical that makes a real difference to the lives of people with dementia and their families.

7. Responding to the changing world of dementia research

As attitudes and approaches to dementia continue to change, our research strategy will remain flexible so we can quickly react to and capitalise on new research opportunities that arise in the coming years.